Ausgabe 1/2010
Inhalt (32 Artikel)
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
Francesca De Amicis, Janagi Thirugnansampanthan, Yukun Cui, Jennifer Selever, Amanda Beyer, Irma Parra, Nancy L. Weigel, Matthew H. Herynk, Anna Tsimelzon, Michael T. Lewis, Gary C. Chamness, Susan G. Hilsenbeck, Sebastiano Andò, Suzanne A. W. Fuqua
Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation
Jane Wenzel, Reiner Zeisig, Wolfram Haider, Sylvia Habedank, Iduna Fichtner
Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures
Ghaffar Muharram, Emilie Le Rhun, Ingrid Loison, Pierre Wizla, Audrey Richard, Nathalie Martin, Annie Roussel, Agnes Begue, Patrick Devos, Marie-Christine Baranzelli, Jacques Bonneterre, Perrine Caillet-Fauquet, Dominique Stehelin
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer
Einar Gudlaugsson, Ivar Skaland, Emiel A. M. Janssen, Paul J. van Diest, Feja J. Voorhorst, Kjell Kjellevold, Axel zur Hausen, Jan P. A. Baak
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer
H. Zhang, E. A. Rakha, G. R. Ball, I. Spiteri, M. Aleskandarany, E. C. Paish, D. G. Powe, R. D. Macmillan, C. Caldas, I. O. Ellis, A. R. Green
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Antoinette Hollestelle, Jord H. A. Nagel, Marcel Smid, Suzanne Lam, Fons Elstrodt, Marijke Wasielewski, Ser Sue Ng, Pim J. French, Justine K. Peeters, Marieke J. Rozendaal, Muhammad Riaz, Daphne G. Koopman, Timo L. M. ten Hagen, Bertie H. C. G. M. de Leeuw, Ellen C. Zwarthoff, Amina Teunisse, Peter J. van der Spek, Jan G. M. Klijn, Winand N. M. Dinjens, Stephen P. Ethier, Hans Clevers, Aart G. Jochemsen, Michael A. den Bakker, John A. Foekens, John W. M. Martens, Mieke Schutte
Antimitotic chemotherapeutics promote adhesive responses in detached and circulating tumor cells
Eric M. Balzer, Rebecca A. Whipple, Edward H. Cho, Michael A. Matrone, Stuart S. Martin
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor
Loredana Mauro, Michele Pellegrino, Rosamaria Lappano, Adele Vivacqua, Francesca Giordano, Maria Grazia Palma, Sebastiano Andò, Marcello Maggiolini
Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study
Jeanne Debess, Jens Østergaard Riis, Malene Cramer Engebjerg, Marianne Ewertz
Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial
Christian R. Loehberg, Sebastian M. Jud, Lothar Haeberle, Katharina Heusinger, Gerhard Dilbat, Alexander Hein, Claudia Rauh, Peter Dall, Nadine Rix, Sabrina Heinrich, Stefan Buchholz, Benno Lex, Barbara Reichler, Boris Adamietz, Ruediger Schulz-Wendtland, Matthias W. Beckmann, Peter A. Fasching
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198
Antonio C. Wolff, Molin Wang, Hailun Li, Michael R. Pins, Florence J. Pretorius, Kendrith M. Rowland, Joseph A. Sparano, Nancy E. Davidson
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
Carlos H. Barrios, Mei-Ching Liu, Soo Chin Lee, Laurence Vanlemmens, Jean-Marc Ferrero, Toshio Tabei, Xavier Pivot, Hiroji Iwata, Kenjiro Aogi, Roberto Lugo-Quintana, Nadia Harbeck, Marla J. Brickman, Ke Zhang, Kenneth A. Kern, Miguel Martin
Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start?
Andreas Brandt, Justo Lorenzo Bermejo, Jan Sundquist, Kari Hemminki
Breast cancer screening recommendations: dynamic extrapolation of limited data
Colin Mooney, Sofia Merajver
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population
Maria A. Loizidou, Marios A. Cariolou, Susan L. Neuhausen, Robert F. Newbold, Evy Bashiardes, Yiola Marcou, Thalia Michael, Maria Daniel, Eleni Kakouri, Panayiotis Papadopoulos, Simon Malas, Andreas Hadjisavvas, Kyriacos Kyriacou
Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations
Ke-Da Yu, Gen-Hong Di, Wen-Feng Li, Nan-Yan Rao, Lei Fan, Wen-Tao Yuan, Zhen Hu, Jiong Wu, Zhen-Zhou Shen, Wei Huang, Zhi-Ming Shao
IGF-I during primiparous pregnancy and maternal risk of breast cancer
Tianhui Chen, Annekatrin Lukanova, Kjell Grankvist, Anne Zeleniuch-Jacquotte, Marianne Wulff, Robert Johansson, Helena Schock, Per Lenner, Goran Hallmans, Goran Wadell, Paolo Toniolo, Eva Lundin
Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis
Ni Li, Jing Dong, Zhibin Hu, Hongbing Shen, Min Dai
Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk
Thomas Dünnebier, Justo Lorenzo Bermejo, Susanne Haas, Hans-Peter Fischer, Christiane B. Pierl, Christina Justenhoven, Hiltrud Brauch, Christian Baisch, Michael Gilbert, Volker Harth, Anne Spickenheuer, Sylvia Rabstein, Beate Pesch, Thomas Brüning, Yon-Dschun Ko, Ute Hamann
GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis
Theodoros N. Sergentanis, Konstantinos P. Economopoulos
Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort
N. M. McInerney, N. Miller, A. Rowan, G. Colleran, E. Barclay, C. Curran, M. J. Kerin, I. P. Tomlinson, E. Sawyer
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy
Eugenio Maiorano, Meredith M. Regan, Giuseppe Viale, Mauro G. Mastropasqua, Marco Colleoni, Monica Castiglione-Gertsch, Karen N. Price, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates
A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family
Josefa Salgado, José M. Aramendía, Cristina Gutierrez, Carmen Gil, Maitane Robles, Jesús García-Foncillas
A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer
Orland Diez, Sara Gutiérrez-Enríquez, Carmen Mediano, Miriam Masas, Cristina Saura, Neus Gadea, Judith Balmaña
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer
Luciane R. Cavalli, Rebecca B. Riggins, Antai Wang, Robert Clarke, Bassem R. Haddad
A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells
Yuan Yao, Qun Zhou
Fetal microchimerism in breast from women with and without breast cancer
Vijayakrishna K. Gadi
Sensitivity analyses including and excluding the HWE-violating studies are required for meta-analyses of genetic association studies
C. Mao, R. Y. Liao, Q. Chen
Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer
A-Yong Cao, Zhen Hu, Wen-Jin Yin, Wei Jin, Zhi-Ming Shao
Estrogen receptor regulation: don’t forget translation
Laura Smith, Valerie Speirs, Thomas A. Hughes
Are PALB2 mutations associated with increased risk of male breast cancer?
A. Sauty de Chalon, Z. Teo, D. J. Park, F. A. Odefrey, J. L. Hopper, M. C. Southey
Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population
Eva Esteban Cardeñosa, Pascual Bolufer Gilabert, Inmaculada de Juan Jimenez, Sarai Palanca Suela, Eva Barragán González, Isabel Chirivella González, Ángel Segura Huerta, Carmen Guillén Ponce, Eduardo Martínez de Dueñas